Monoclonal antibodies blocking CGRP for prevention of migraine
Introduction and purpose Monoclonal antibodies blocking calcitonin gene-related peptide (CGRP) are a novel treatment strategy developed specifically for prevention of migraine. Four drugs belong to this group: eptinezumab, fremanezumab and galcanezumab, which bind to the peptide; and erenumab, w...
| Published in: | Journal of Education, Health and Sport |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2023-04-01
|
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/43098 |